Viewing Study NCT05626257


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2025-12-27 @ 2:45 AM
Study NCT ID: NCT05626257
Status: COMPLETED
Last Update Posted: 2025-11-21
First Post: 2022-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module